Intellectual disability (ID) comprises a group of mental disorders which have underlying genetic causes, among which the monogenic causes are one of the causes for ID. One kind of a monogenic cause is the copy number variations (CNVs). These CNVs can be indicated using exome sequencing (ES) and the CoNVex and CoNIFER algorithms. To confirm the possible causative CNVs quantitative PCR (QPCR) was used. In a Pakistani ID patient a homozygous deletion of ENTPD3 was indicated and in an Estonian ID patient CPVL-CHN2 a homozygous duplication was indicated. However the QPCR showed that ENTPD3 did not segregate and CPVL-CHN2 was only duplicated heterozygous. Confirmation, like QPCR, is therefore a crucial step in confirming CNVs analysis of ES in ID patients.
Introduction
An intellectual disability (ID) is classified by a significant limitations in adaptive functioning from at least two of the following skill areas: self-direction, work, leisure, health, communication, home living, use of community resources, social or interpersonal skills, functional academic skills or safety (1) . On top of that an onset before the 18 years and a low IQ (<70) are classifications of an ID. There is a subdivision of four degrees of severity of ID based on IQ, the mild ID (IQ 50-69), the moderate ID (IQ 35-49), the severe ID (IQ 20-34) and profound ID (IQ <20). The prevalence of total ID is about 1% of the total population, and for severe ID it is 0.6% (1) . IDs are among the largest cost factors for healthcare. In 2010 about 5% of the total health costs for brain disorders in Europe were due to ID (2) .
IDs can be caused by environmental factors, such as malnutrition during pregnancy, premature birth, pre-and postnatal infections, exposure to neurotoxic compounds and peri-and postnatal asphyxia or other traumas. These environmental factors have a greater contributing factor than monogenic causes to develop mild ID. However, in patients with severe ID genetic causes are observed more frequently than environmental factors as the cause of ID. Mutations in more than 450 different genes can give rise to ID and related cognitive disorders. The discovery of causative ID genes, from which about 14.2% of the monogenic causes are either a duplication or deletion of a gene region, has risen and will be rising due to innovations and implementation of DNA sequencing techniques (3, 4) .
Exome sequencing (ES) is a technique to determine the sequence of the DNA sequencing.
With ES the protein coding regions, thus the exome, are mapped. These regions together constitute 1-2% of the whole human genome and harbor more than 60% of pathogenic mutations in heritable disorders (5, 6) . ES generates reads, which are parts of DNA that are sequenced, of exonic regions. The aligned reads and a genetic reference database are used to check genetic variations. These differences can be mutations like insertions of nucleotides, deletions of nucleotides or substitution of nucleotides.
Exome sequencing makes use of relatively small reads, about <250 base pairs (bp) long.
When a region far greater than these 250 bp is duplicated or deleted, it has no use to compare the reads to a reference database, because the system will see this region as a bad sequenced region rather than a big deletion. Small copy number variations (CNVs), which are deletions and duplications, greater than the 250 bp can be calculated by using the read density of ES data. To calculate the CNVs the number of reads of a genetic region of a person is compared to the mean reads of the other genes of the person. These reads should give an average coverage from the reads of the genes. A second way to calculate the CNVs is using a reference database, in which the average reads coverage of controls is used. If there are more or less reads in a region, it can indicate that there are respectively more or less copies of that gene (7, 8) .
Another way to measure CNVs is using quantitative polymerase chain reaction (QPCR). The high costs of ID and the great contribution of CNVs to the onset of ID led to the aim of this study to identify causative CNVs in patients with ID from exome data by using algorithms and QPCR confirmation.
Material and methods
CNVs were identified by the tools CoNVex (Copy number variation estimation in exome sequencing) with a score above 5.0 or CoNIFER (Copy number inference from exome reads) with a score above 3.0 for duplications or below -3.0 for deletions. The deletions that were indicated by either CoNVex or CoNIFER were checked in the ES data if the exonic region was really deleted.
For confirmation a genomic quantitative PCR (QPCR) was performed. If indicated necessary, also the family members were analysed. Primers were designed using Primer3Plus
(www.bioinformatics.nl/cgibin/primer3plus/primer3plus.cgi/). The FASTA sequence was obtained from UCSC using the GRCh37/hg19. Product size 80-120bp, primer size 18-24bp, GC 40-60%, Melting temperature 58-62ºC (∆Tm <1ºC) and a GC clamp set to 1. Using the in silico PCR and blat from UCSC and SNPcheck primers were checked for specificity.
Primers to determine the copy number of ENTPD3 were designed in a way that the whole gene was covered (Exon 2, 4, 6, 8 and 10) and two flanking references genes were included, namely MYRIP exon 17 and RPL14 exon 2 (figure 1). Primers to determine the copy number of CPVL-CHN2 were designed in a way that one exon before and after the indicated exon were taken into account, thus for CPVL exon 1, 2 and 3 and for CHN2 exon 7, 8 and 9. Also one flanking reference gene was taken into account, namely PRR15 ( Figure 2 ). The QPCR mix per reaction consisted of 12.5µL GoTaq2x master mix, 2.5µL 3µM forward primer, 2.5µL 3µM reverse primer, 2.5µL MilliQ and 5µL (1ng/µL) DNA sample were used.
Two control samples and one negative were included and everything was performed in duplo. As reference, primers for the BRWD3 gene on the X-chromosome were used.
The Applied Biosystmes Fast 7500 system with SYBR green was used to perform the QPCR.
The stages were
• Stage 1 (1x): 95.0ºC for 10:00 minutes
• Stage 2 (40x): 95.0ºC for 15 seconds / 60ºC for 15 seconds.
• Stage 3 (1x): 95.0ºC for 15 seconds / 60ºC for 15 seconds.
• Stage 4 (1x): 95.060ºC for 15 seconds.
The exact copy number was calculated as follows: Copy number of gene = 2*2 ∆∆Ct where ∆∆Ct=∆Ct patient -∆Ct control and ∆Ct = Ct reference gene -Ct gene of interest . The Ct value was obtained by setting the threshold in a way that most of the lines were parallel An independent T-test was used to calculate the significance of the copy numbers using the QPCR 2*2 ∆∆Ct (9). This duplication should reach approximately from exon 2 of CPVL until exon 8 of CHN2.
Confirmation
For as there was almost no DNA available from 59792 the DNA of his brother (55192), who was also affected, was used. Genomic QPCR analysis, via copy number calculation, showed a copy number of one of the ENTPD3 gene in the Pakistani index patient's affected brother.
The controls and the reference genes all had a copy number of two (figure 4). Hereafter a Genomic QPCR was performed on 59800 (IV:2), 59793 (IV:12) and 59794 (IV:13) (figure 5).
These results were that IV:2 and IV:12 had a heterozygous deletion of ENTPD3 and IV:13 a total deletion. Genomic QPCR analysis, via copy number calculation, showed in the Estonian family that both sisters had a copy number of two of the CPVL gene and copy number of three of the CHN2 gene. The controls and reference had a copy number of two (figure 6). In this study we used two different algorithms for the calculation of CNVs. This might seem inconsequent, yet the opposite is true. The algorithms were chosen in a way that they served the ES and QPCR methods used in our lab at best. So is CoNVex optimized for UK10K ES files and CoNIFER for non paired exome CNV detection (8, 10) . SYBR® Green also
shows good results for cross-platform comparison and is a very reliable tool (11) . However in essence it differs from some other QPCR mixes. SYBR® Green solution uses Non-specific detection, on the other hand there are techniques, for example the TaqMan probe, that use specific detection with the usage of probes. Where the SYBR® Green releases fluorescent every time there is an amplification reaction because it binds between double stranded DNA, the TaqMan probe binds to a region, directly after region of the primers. This results in fluorescent release after the amplification of the DNA. This technique is more specific than the SYBR Green, although also more expensive.
The ENTPD3 gene codes for Ectonucleoside triphosphate diphosphohydrolases, which is a class of enzymes that dephosphorylate extracellular ATP and ADP, thus taking phosphate groups of ATP or ADP. In a knockout mouse study it was shown that pair reception did not change, as what they expected. Though they did not test for intelligence of the mice (12) . Therefore ENTPD3 seemed a likely ID gene. For CPVL-CHN2 it is a different story.
Most publication with reference to those two genes are for diabetics, and none about intellectual disorders. For searches alone on the CPVL, it has a more important function in macrophage. However the CHN2 gene has high expression levels in the brain and pancreas,
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has a role in cell proliferation and migration. Thus a error in the construct of the CHN2 gene might have made it a possible ID gene (13) . What also indicated that these genes might be causative ID genes, is the fact that when looking in online databases of genes. There seems to be almost no loss of function genes (indicating nonsense frameshift or splice site mutations) of the ENTPD3, CPVL and CHN2 genes according to the ExAC database. This database contains the genome of >60,000 unrelated individuals (14) .
Exact copy numbers of the genes could not be readily extracted from exome data, as only a duplication of one allele rather than two in the Estonian sisters was found. Adjusting and formulating the conclusion was done by the student.
